Chonluten targets bronchial mucosal tissue with precision short-chain peptides. It supports the body's mucociliary escalator—the self-cleaning mechanism of the airways—while promoting epithelial cell turnover for clearer, more comfortable breathing.
Chonluten is a precision-engineered bioregulator peptide that selectively targets bronchial mucosa through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within bronchial mucosa cells, Chonluten helps normalise mucociliary clearance and bronchial epithelial repair—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for respiratory tissue maintenance, making it a fundamentally different approach from conventional supplementation.